Strong Bonds Stand the Test of Time

Geovanna, a ZEVASKYN patient at age 8

Strong Bonds Stand the Test of Time

ZEVASKYN is made from your own skin cells to deliver long-lasting wound healing—even in tough RDEB wounds*

  • 81% of ZEVASKYN-treated wounds healed by 50% or more when measured at 6 months†
View long-term wound healing images Right-open Right-open
  • RDEB=recessive dystrophic epidermolysis bullosa.
  • *Wounds treated had remained open for at least 6 months.
  • †ZEVASKYN-treated wounds were compared to similar wounds treated with typical wound care in 11 RDEB patients as part of a clinical trial. 81% of ZEVASKYN-treated wounds (35 of 43) healed by 50% or more vs 16% of matched control wounds (7 of 43).

Real people with RDEB have experienced healing with ZEVASKYN

Discover their stories Right-open Right-open

Find ZEVASKYN support and get all of your treatment questions answered

Hand holding heart icon

Personalized support when you need it, with Abeona Assist™

If you are considering ZEVASKYN or have questions about treatment, Abeona Assist™ is your dedicated support partner every step of the way.

Find Support Right-open Right-open
Speech bubble icon

Talk to ZEVASKYN patients and caregivers about their experience

Through the Strong Together Network, you can connect with a patient or caregiver who has experience with ZEVASKYN treatment.

Get in Touch Right-open Right-open
Treatment center icon

Locate a ZEVASKYN Qualified Treatment Center

Treatment is only available at qualified treatment centers. See the list of current ZEVASKYN Qualified Treatment Centers.

Locate a Center Right-open Right-open

What is ZEVASKYN?

ZEVASKYN™ (prademagene zamikeracel) is a type of gene therapy made from your own skin cells that is surgically applied to treat wounds in both children and adults who have recessive dystrophic epidermolysis bullosa (RDEB).

Important Safety Information

  • Serious allergic reactions to ZEVASKYN can occur. Get medical help right away if you or your child experience symptoms like itching, swelling, hives, difficulty breathing, runny nose, watery eyes, or nausea. In rare cases, a severe reaction called anaphylaxis may happen.
  • There is a potential risk that treatment with ZEVASKYN may contribute to the development of cancer because of how the therapy works.  Patients should be monitored for the rest of their lives to check for any signs of cancer.
  • ZEVASKYN is made using human and animal materials. Although these materials are tested before use, the risk of passing on infections cannot be eliminated.
  • The most common side effects are pain from the procedure and itching.

This is not a complete list of side effects. Call your care team for medical advice about side effects. You may report side effects to Abeona at 1-844-888-2236 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Post-Application Care

  • You may feel pain or itching at the treated area as it heals. Contact your doctor if you have: fever, increased drainage, worsening pain or swelling, or any other symptoms at or near the treated area.
  • Do not disturb the surgical dressing for 5—10 days, unless your doctor tells you otherwise.
  • Keep the dressing(s) dry. Do not soak the treated area(s) in water (like in a bath or pool) until the gauze backing falls off of the treated area(s), approximately 2—3 weeks after the surgery.

Product Manufacturing

  • ZEVASKYN is made from your own skin cells. In rare cases, the manufacturing process may not work. If this happens, your doctor may suggest taking another skin biopsy to repeat the manufacturing process.

Please see full Prescribing Information.

What is ZEVASKYN?

ZEVASKYN™ (prademagene zamikeracel) is a type of gene therapy made from your own skin cells that is surgically applied to treat wounds in both children and adults who have recessive dystrophic epidermolysis bullosa (RDEB).

Important Safety Information

  • Serious allergic reactions to ZEVASKYN can occur. Get medical help right away if you or your child experience symptoms like itching, swelling, hives, difficulty breathing, runny nose, watery eyes, or nausea. In rare cases, a severe reaction called anaphylaxis may happen.
  • There is a potential risk that treatment with ZEVASKYN may contribute to the development of cancer because of how the therapy works.  Patients should be monitored for the rest of their lives to check for any signs of cancer.
  • ZEVASKYN is made using human and animal materials. Although these materials are tested before use, the risk of passing on infections cannot be eliminated.
  • The most common side effects are pain from the procedure and itching.

This is not a complete list of side effects. Call your care team for medical advice about side effects. You may report side effects to Abeona at 1-844-888-2236 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Post-Application Care

  • You may feel pain or itching at the treated area as it heals. Contact your doctor if you have: fever, increased drainage, worsening pain or swelling, or any other symptoms at or near the treated area.
  • Do not disturb the surgical dressing for 5—10 days, unless your doctor tells you otherwise.
  • Keep the dressing(s) dry. Do not soak the treated area(s) in water (like in a bath or pool) until the gauze backing falls off of the treated area(s), approximately 2—3 weeks after the surgery.

Product Manufacturing

  • ZEVASKYN is made from your own skin cells. In rare cases, the manufacturing process may not work. If this happens, your doctor may suggest taking another skin biopsy to repeat the manufacturing process.

Please see full Prescribing Information.

Abeona Therapeutics® logo

ZEVASKYN, Abeona Assist, and the related logos are registered trademarks of Abeona Therapeutics Inc. All other trademarks are the property of their respective owners.

© 2025 Abeona Therapeutics Inc. All rights reserved. US-COM-ZEV-250005  05/25